The U.S. laboratory disposable products market size was estimated at USD 1.6 billion in 2022 and is expected to hit around USD 3.52 billion by 2032, poised to reach at a notable CAGR of 8.2% during the forecast period 2023 to 2032.
Key Takeaways:
U.S. Laboratory Disposable Products Market Report Scope
Report Attribute | Details |
Market Size in 2023 | USD 1.73 Billion |
Market Size by 2032 | USD 3.52 Billion |
Growth Rate From 2023 to 2032 | CAGR of 8.2% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Product, material, end-use, region |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Key Companies Profiled | Cardinal Health; Thomas Scientific; Medicus Health; Therapak; Dynarex Corporation; Thermo Fisher Scientific Inc.; McKesson Corporation; Medline Industries, Inc.; Becton Dickinson |
The rising demand for plastics in healthcare industry owing to its advantages, such as light-weight, cost-effectiveness, biocompatibility, and versatility is projected to drive the market. Favorable laboratory insurance policies are expected to further fuel growth.
Use of disposable products in laboratories avoids contamination of medical products and offers better safety to patients. Moreover, use of disposable products instead of reusable products eliminates the reprocessing procedure. This factor is also expected to augment the demand for laboratory disposable products from the U.S. healthcare industry.
Introduction of novel technologies and trends are expected to fuel the growth of the laboratory disposables market in the U.S. Some of the most popular trends include automation, cloud technology, compact equipment, and eco-friendly products. Automation is not a new trend in laboratories, but it is witnessing increasing adoption in various fields including robotics, primary screening, genomics, and proteomics. Automation tools allow researchers to perform the entire process efficiently.
Lab equipment is integrated with cloud technology for data recording and storage. The use of cloud technology is anticipated to witness significant growth in laboratory settings as the labs seek advanced data storage options that offer optimum accessibility to the advanced laboratory equipment. With cloud integration, technicians can get updates and alerts on their smartphones about cycles and lab processes. These alerts allow technicians to monitor laboratory procedures and respond to emergencies more efficiently.
In addition, rising use of disposable products to avoid infectious diseases and product contamination, is also expected positively influence growth of the U.S. laboratory disposable products market. Single-use medical plastics prevent the spread of serious infectious diseases. However, improper recycling of these materials could increase the risk of infection. This encourages the use of glass, metal, and other such alternatives. Having said that, availability, transportation, and inability to decontaminate are some of the basic challenges with these alternatives.
Rise in research studies and advancements in chemical, life science, and food and beverage industries to meet the growing demand are anticipated to augment the demand for laboratory disposables, thereby driving the growth of the U.S. market.
Product Insights
Specimen containers segment held the largest market share of 60.8% in 2022, due to an increase in a number of patients in the U.S. Rise in geriatric population in the U.S. is one of the major factors fuelling the product demand. Moreover, high prevalence of chronic disorders and rising geriatric population is also expected to drive the demand for laboratory disposable products. Growing incidence of various diseases demand pathological examination of urine, blood, stool, and sputum, which requires different disposables to confirm the diagnosis and to carry out a treatment plan.
Tissue collectors segment, on the other hand, is anticipated to register the highest CAGR of 9.7% over the forecast period. High prevalence of different types of cancer is anticipated to drive the segment growth. A high prevalence of cancer is expected to drive the product demand in the near future. Tissue examination is widely used for detecting different types of cancer. According to the National Cancer Institute, approximately 1,735,350 new patients were diagnosed with cancer in 2018, of which 609,640 cases resulted in death. Some common types of cancer reported in the country are lung and bronchus, prostate, breast, melanoma, bladder, colon, and rectal cancer.
Material Insights
The plastic segment is anticipated to continue holding the leading market share over the forecast period. The physical properties of plastic, easy availability, and increasing use of medical plastic disposables is projected to drive the growth of the segment. Glass segment is anticipated to expand at the fastest CAGR of over 9.0% over the forecast period. A large amount of medical plastic waste is generated in the U.S., which is leading to a shift in usage from plastic to glass laboratory disposable products. Rising preference for eco-friendly products is expected to bode well for the segment growth. For instance, in 2016, Greenhealth Exchange, an online marketplace, was launched by four major healthcare companies and two NGOs in the U.S. to promote green products, ranging from IV tubes to cafeteria food.
According to a research article published by the National Center for Biotechnology Information (NCBI) in 2015, 20 pounds of plastic waste is produced from a single hysterectomy procedure in U.S. According to the Center for Chronic Disease Prevention (CDC), six in every 10 adults in U.S. suffer from a chronic disease. Increasing prevalence of chronic diseases is projected to boost the demand for hospital treatments and procedures. High demand for laboratory disposables in healthcare centers for diagnosis and other medical purposes on a daily basis is expected to fuel the growth in the near future.
End-Use Insights
The CROs segment is expected to hold the largest market share owing to an increase in outsourcing by companies to save their time and to reduce investment. The hospital segment is expected to expand at a lucrative CAGR over the forecast period. The rapid growth can be attributed to increasing prevalence of cancer and chronic diseases in the U.S.
According to the Agency for Healthcare Cost and Utilization Project, in 2014, 10.1 million patients in hospital stay, underwent operating room procedures. As per the Leukemia and Lymphoma Society, in 2019, one person is diagnosed with blood cancer every 3 minutes in the U.S. Thus, there has been a rise in the number of hospitals stays and the prevalence of cancer and other chronic diseases in the country. Presence of a large patient pool is anticipated to increase the number of diagnostic tests performed, thereby driving the demand for laboratory disposables.
Recent Developments
In May 2022, Cardinal Health and URAC, have established a partnership to assist Cardinal Health customers with a specialty pharmacy and practice compliance. Cardinal Health customers will be given discounted pricing for all URAC accreditation bodies as part of the arrangement with URAC, which validates that a pharmacist satisfies the industry's most stringent criteria and indicates the quality of the therapeutic services it delivers
In February 2021, Thomas Scientific teamed up with Foxx Life Sciences to make ordering media bottles easier. The product will be customizable and orderable through a direct-to-consumer website located on the Thomas Scientific website
In March 2022, Cardinal Health announced intentions to construct a medical dispensation hub near Columbus, Ohio. The new structure will incorporate automation and software to serve closely Cardinal Health staff to improve security, services, and quality, create productivity improvements, and better accommodate volume and labor changes to give consumers an expected and stable experience
Some of the prominent players in the U.S. laboratory disposable products market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Laboratory Disposable Products market.
By Product
By Material
By End-Use Type
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Laboratory Disposable Products Market
5.1. COVID-19 Landscape: U.S. Laboratory Disposable Products Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Laboratory Disposable Products Market, By Product
8.1. U.S. Laboratory Disposable Products Market, by Product, 2023-2032
8.1.1 Specimen Containers
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Transport Vials
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Collection and Transport Swabs
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Tissue Collectors
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Laboratory Disposable Products Market, By Material
9.1. U.S. Laboratory Disposable Products Market, by Material, 2023-2032
9.1.1. Glass
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Plastic
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. U.S. Laboratory Disposable Products Market, By End-Use Type
10.1. U.S. Laboratory Disposable Products Market, by End-Use Type, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. CROs
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. U.S. Laboratory Disposable Products Market, Regional Estimates and Trend Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Material (2020-2032)
11.1.3. Market Revenue and Forecast, by End-Use Type (2020-2032)
Chapter 12. Company Profiles
12.1. Cardinal Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thomas Scientific
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medicus Health
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Therapak
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Dynarex Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thermo Fisher Scientific Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. McKesson Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medline Industries, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Becton Dickinson
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms